Cross-Disease Integration Identifies Inflammation-Related Candidate Biomarkers for Atherosclerosis and Candidate Therapeutic Compounds Using Bioinformatics, Machine Learning, and Molecular Dynamics Simulations
Current Issues in Molecular Biology · 17.11.2026 · 48 (11) · 1242
DOI: 10.3390/cimb48111242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.11.2026. Verfasst von Meidong Si und 5 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningxia Medical University.
Abstract (Originalsprache)
Objective
This study aimed to establish a translational research framework integrating cross-disease computational screening with experimental validation. Using Helicobacter pylori (H. pylori) infection as a cross-disease inflammatory comparator, we systematically identified atherosclerosis-associated hub genes through integrated bioinformatics and machine-learning analyses, evaluated their potential diagnostic value in independent datasets, and validated their protein expression in a mouse model of atherosclerosis (AS).
Methods
GEO gene-expression datasets were analyzed using differential expression analysis, WGCNA, functional enrichment, and machine-learning algorithms. CIBERSORT was used to assess immune-cell infiltration and gene–immune associations in AS and H. pylori infection. miRNA–mRNA–TF and TF–hub gene networks were constructed. Candidate compounds were predicted using DGIdb, followed by molecular docking, molecular dynamics simulations, and in vivo validation.
Results
Integration of differential expression analysis and WGCNA identified 656 candidate genes associated with AS and H. pylori infection. Eleven key genes were subsequently identified using MCODE and cytoHubba. Machine-learning analysis further identified CX3CR1 and TNF as potential diagnostic biomarker candidates. ROC curve analysis demonstrated that CX3CR1 exhibited more consistent discriminatory performance across datasets, whereas TNF showed considerable variability in diagnostic performance, particularly in the independent validation cohorts. These findings should be interpreted cautiously given the limited sample sizes of some cohorts. Immune infiltration analysis revealed associations between CX3CR1, TNF, and immune dysregulation related to H. pylori infection and AS. Additionally, miRNA–mRNA–TF regulatory network analysis suggested that these two genes may be involved in inflammatory signaling pathways associated with disease progression. Molecular docking and molecular dynamics simulations indicated that the selected small-molecule compound exhibited favorable binding affinity for the target protein and formed a structurally stable complex. In vivo experiments demonstrated that CX3CR1 and TNF protein levels were significantly increased in atherosclerotic lesions in an AS mouse model.
Conclusions
Using a two-stage strategy combining cross-disease computational screening with experimental validation, we identified CX3CR1 and TNF as candidate inflammation-related biomarkers associated with AS and H. pylori infection. CX3CR1 demonstrated more consistent diagnostic potential than TNF across the analyzed datasets. In vivo validation revealed significant upregulation of both proteins in atherosclerotic lesions, supporting their potential involvement in AS pathogenesis. Collectively, these findings suggest that CX3CR1 may represent a promising candidate diagnostic biomarker for atherosclerosis, whereas the diagnostic performance and pathological significance of TNF require further investigation.
Förderung
- Ningxia Medical University
Zitieren
APA
Si, M., Ma, X., Yang, Y., Tian, X., Yang, Y., & Zhou, R. (2026). Cross-Disease Integration Identifies Inflammation-Related Candidate Biomarkers for Atherosclerosis and Candidate Therapeutic Compounds Using Bioinformatics, Machine Learning, and Molecular Dynamics Simulations. Current Issues in Molecular Biology, 48(11), 1242. https://doi.org/10.3390/cimb48111242
Vancouver
Si M, Ma X, Yang Y, Tian X, Yang Y, Zhou R. Cross-Disease Integration Identifies Inflammation-Related Candidate Biomarkers for Atherosclerosis and Candidate Therapeutic Compounds Using Bioinformatics, Machine Learning, and Molecular Dynamics Simulations. Current Issues in Molecular Biology. 2026;48(11):1242. doi:10.3390/cimb48111242
BibTeX
@article{Si2026,
author = {Si, Meidong and Ma, Xuemei and Yang, Yani and Tian, Xinze and Yang, Yaodong and Zhou, Ru},
title = {Cross-Disease Integration Identifies Inflammation-Related Candidate Biomarkers for Atherosclerosis and Candidate Therapeutic Compounds Using Bioinformatics, Machine Learning, and Molecular Dynamics Simulations},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {11},
pages = {1242},
doi = {10.3390/cimb48111242}
}
EUVIMED